Zynex Inc. (ZYXI) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Zynex Inc. (ZYXI:NASDAQ), powered by AI.

Current Price
$0.06
P/E Ratio
0.6
Market Cap
2M
Sector
Healthcare
What is the Zynex Inc. stock price forecast?

Zynex Inc. is currently trading at $0.06. View real-time AI analysis on Alpha Lenz.

What is Zynex Inc. insider trading activity?

View the latest insider trading data for Zynex Inc. on Alpha Lenz.

What is Zynex Inc.'s P/E ratio?

Zynex Inc.'s P/E ratio is 0.6.

Zynex Inc.

NASDAQ · ZYXI
$0.06+0.00(+5.77%)Pre-marketNASDAQ regular session 09:30–16:00 ET
Ask about Zynex Inc.'s future dividend policy...
Alpha Chat Insight

Zynex Inc. trades at a P/E of 0.6 (undervalued) with modest ROE of 7.3%. 3Y revenue CAGR of 13.9% highlights clear growth momentum.

Ask for details

Company Overview

Zynex Inc. is a prominent medical device manufacturer specializing in the development and marketing of non-invasive medical devices for pain management, physical rehabilitation, neurological diagnostics, and cardiovascular monitoring. The company is noted for its cutting-edge electrotherapy products, such as its flagship NexWave device, which aims to provide effective pain relief and muscle stimulation to patients. Zynex Inc. serves a diverse clientele, including hospitals, clinics, and individual healthcare providers, enabling enhanced patient care and recovery outcomes. Its devices are integral in post-operative care and various therapeutic protocols. Founded in 1996 and headquartered in Englewood, Colorado, Zynex Inc. plays a critical role in the healthcare industry by delivering solutions that improve patient quality of life while reducing reliance on pharmaceuticals. Through its innovative approach, Zynex strives to address the growing demand for alternative pain solutions, consequently supporting the broader trend of personalized healthcare management.

CEOMr. Thomas Sandgaard
SectorHealthcare
IndustryMedical Distribution
Employees1,000

Company Statistics

FY 2024

Profile

$1.76MMarket Cap
$192.35MRevenue
0.00Shares Out
1,000Employees

Margins

79.50%Gross
5.60%EBITDA
3.11%Operating
1.89%Pre-Tax
1.56%Net

Valuation

0.59P/E
0.05P/B
0.01EV/Sales
3.34EV/EBITDA
0.14P/FCF

Growth (CAGR)

13.86%Rev 3Yr
33.44%Rev 5Yr
-35.54%Op Inc 3Yr
-11.55%Op Inc 5Yr
-44.06%Net Inc 3Yr
-20.61%Net Inc 5Yr

Returns

2.31%ROA
7.32%ROE
4.64%ROIC

Financial Health

$39.63MCash & Cash Equivalents
$46.74MNet Debt
241.88%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Zynex Inc. (ticker: ZYXI) is a company listed on NASDAQ in the Healthcare sector (Medical Distribution). It has approximately 1,000 employees. Market cap is $2M.

The current price is $0.055 with a P/E ratio of 0.59x and P/B of 0.05x.

ROE is 7.32% and operating margin is 3.11%. Annual revenue is $192M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Zynex Inc. (ZYXI) Stock Forecast 2026 $0.06 — Price, Financials & Analyst Targets | Alpha Lenz